A Massachusetts-based biotech company is stealing the show so far during Tuesday’s premarket hours after it was announced that it has entered into an exclusive license and...

To read the full story on AllPennyStocks.com, click here.

C4 Therapeutics (NASDAQ:CCCC)
過去 株価チャート
から 4 2024 まで 5 2024 C4 Therapeuticsのチャートをもっと見るにはこちらをクリック
C4 Therapeutics (NASDAQ:CCCC)
過去 株価チャート
から 5 2023 まで 5 2024 C4 Therapeuticsのチャートをもっと見るにはこちらをクリック